← Open Payments lookup

ABDUL KHAN: Open Payments

NPI 1003945221 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$393 in 9 payments from 8 companies in 2025. Trend: 2023 $348 · 2024 $211 · 2025 $393

Food & beverage: $393
CompanyPaymentsAmount
Alkermes, Inc.1$124
Otsuka America Pharmaceutical, Inc.1$122
Insulet Corporation1$38
GlaxoSmithKline, LLC.2$36
E.R. Squibb & Sons, L.L.C.1$19
Novo Nordisk Inc1$19
Lundbeck LLC1$19
ABBVIE INC.1$16

Products named: LYBALVI, ABILIFY MAINTENA, Omnipod, NUCALA, COBENFY, Wegovy, ABILIFY ASIMTUFII, VRAYLAR.

Industry payments across LA — which companies pay providers there.